Tag: KeifeRx LLC’s KFRX01
Novartis’s drug Tasigna faces sales decline
Novartis drug Tasigna (nilotinib) is set to lose its exclusive status in the US in January 2024. A pivotal treatment for chronic myeloid leukemia (CML),...
This function has been disabled for HealthTekPak.